Literature DB >> 21775908

Vascular dysfunction and physical activity in multiple sclerosis.

Sushant M Ranadive1, Huimin Yan, Madeline Weikert, Abbi D Lane, Mellissa A Linden, Tracy Baynard, Robert W Motl, Bo Fernhall.   

Abstract

BACKGROUND: Multiple sclerosis (MS) is an inflammatory disorder of the brain and spinal cord. Disability status and progression are associated with reduced physical activity (PA) and cardiovascular function. Lack of adequate PA combined with inflammation may create high susceptibility to subclinical atherosclerosis and vascular dysfunction.
PURPOSE: The purpose of this study was to compare subclinical atherosclerosis and arterial function between individuals with and without MS matched for age, sex, and body mass index.
METHODS: Thirty-three individuals diagnosed with MS and 33 controls underwent strain gauge plethysmography for resting forearm blood flow (FBF) and peak reactive hyperemia for the microvascular function. Intima-media thickness and arterial compliance (AC) were measured using carotid ultrasound for vascular function. C-reactive protein and PA (7-d accelerometer data) were also measured.
RESULTS: There was a significant difference (P < 0.05) in resting FBF, peak reactive hyperemia, central pulse wave velocity, and AC between the MS and control groups. PA was associated with peak FBF and central pulse wave velocity but not FBF and carotid AC. Individuals with MS exhibit reduced arterial function but similar intima-media thickness compared with controls. Persons with MS had significantly reduced PA levels compared with controls, and PA accounted for differences in arterial function between groups.
CONCLUSIONS: These results indicate that subclinical markers of atherosclerosis are higher in individuals with MS, suggesting a higher risk of cardiovascular disease in this population. However, the higher levels of subclinical atherosclerosis were accounted for by the low PA in persons with MS, suggesting that increasing PA may reduce the increase in cardiovascular disease risk in patients with MS.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21775908     DOI: 10.1249/MSS.0b013e31822d7997

Source DB:  PubMed          Journal:  Med Sci Sports Exerc        ISSN: 0195-9131            Impact factor:   5.411


  20 in total

1.  Social cognitive predictors of physical activity in relapsing-remitting multiple sclerosis.

Authors:  Yoojin Suh; Ina Joshi; Conner Olsen; Robert W Motl
Journal:  Int J Behav Med       Date:  2014-12

Review 2.  Autonomic dysfunction in multiple sclerosis: implications for exercise.

Authors:  Mu Huang; Ollie Jay; Scott L Davis
Journal:  Auton Neurosci       Date:  2014-10-23       Impact factor: 3.145

3.  Subclinical atherosclerosis in patients with relapsing-remitting multiple sclerosis.

Authors:  Tomaž Omerzu; Jožef Magdič; Radovan Hojs; Uroš Potočnik; Mario Gorenjak; Tanja Hojs Fabjan
Journal:  Wien Klin Wochenschr       Date:  2021-04-26       Impact factor: 1.704

4.  Cardiovascular Dysfunction in Multiple Sclerosis.

Authors:  Raluca Ileana Mincu; Lucia Stefania Magda; Maria Florescu; Andreea Velcea; Sorina Mihaila; Diana Mihalcea; Bogdan O Popescu; Adela Chiru; Cristina Tiu; Mircea Cinteza; Dragos Vinereanu
Journal:  Maedica (Bucur)       Date:  2015-09

5.  Outcomes After Functional Electrical Stimulation Cycle Training in Individuals with Multiple Sclerosis Who Are Nonambulatory.

Authors:  Deborah Backus; Blake Burdett; Laura Hawkins; Christine Manella; Kevin K McCully; Mark Sweatman
Journal:  Int J MS Care       Date:  2017 May-Jun

6.  Lower Arterial Cross-Sectional Area of Carotid and Vertebral Arteries and Higher Frequency of Secondary Neck Vessels Are Associated with Multiple Sclerosis.

Authors:  P Belov; D Jakimovski; J Krawiecki; C Magnano; J Hagemeier; L Pelizzari; B Weinstock-Guttman; R Zivadinov
Journal:  AJNR Am J Neuroradiol       Date:  2017-12-07       Impact factor: 3.825

7.  Vascular comorbidities in multiple sclerosis: a nationwide study from Denmark.

Authors:  Anja Thormann; Melinda Magyari; Nils Koch-Henriksen; Bjarne Laursen; Per Soelberg Sørensen
Journal:  J Neurol       Date:  2016-10-03       Impact factor: 4.849

8.  The descriptive epidemiology of daily sitting time as a sedentary behavior in multiple sclerosis.

Authors:  Elizabeth A Hubbard; Robert W Motl; Patricia J Manns
Journal:  Disabil Health J       Date:  2015-06-26       Impact factor: 2.554

Review 9.  Modifiable comorbidities and disability in multiple sclerosis.

Authors:  Shannon Overs; Christina M Hughes; Jodie K Haselkorn; Aaron P Turner
Journal:  Curr Neurol Neurosci Rep       Date:  2012-10       Impact factor: 5.081

Review 10.  Wearable biosensors to monitor disability in multiple sclerosis.

Authors:  Michael J Bradshaw; Samantha Farrow; Robert W Motl; Tanuja Chitnis
Journal:  Neurol Clin Pract       Date:  2017-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.